#rilpivirine — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #rilpivirine, aggregated by home.social.
-
Long-acting injectables can be a good option for people with adherence challenges | aidsmap https://www.aidsmap.com/news/mar-2024/long-acting-injectables-can-be-good-option-people-adherence-challenges “#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”
-
Long-acting injectables can be a good option for people with adherence challenges | aidsmap https://www.aidsmap.com/news/mar-2024/long-acting-injectables-can-be-good-option-people-adherence-challenges “#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”
-
Long-acting injectables can be a good option for people with adherence challenges | aidsmap https://www.aidsmap.com/news/mar-2024/long-acting-injectables-can-be-good-option-people-adherence-challenges “#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”
-
Long-acting injectables can be a good option for people with adherence challenges | aidsmap https://www.aidsmap.com/news/mar-2024/long-acting-injectables-can-be-good-option-people-adherence-challenges “#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”
-
Long-acting injectables can be a good option for people with adherence challenges | aidsmap https://www.aidsmap.com/news/mar-2024/long-acting-injectables-can-be-good-option-people-adherence-challenges “#Antiretroviral therapy (#ART) using #cabotegravir and #rilpivirine injections monthly or every other month can be an effective HIV treatment option for people who have difficulty maintaining viral suppression on daily pills due to suboptimal adherence, according to studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2024).”